日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/06/25 | 3,111 | 3,132 | 3,074 | 3,120 | +16 | +0.5% | 802,400 |
| 2025/06/24 | 3,111 | 3,140 | 3,087 | 3,104 | +10 | +0.3% | 836,800 |
| 2025/06/23 | 3,333 | 3,349 | 3,094 | 3,094 | -306 | -9% | 1,155,400 |
| 2025/06/20 | 3,421 | 3,436 | 3,391 | 3,400 | -42 | -1.2% | 241,400 |
| 2025/06/19 | 3,500 | 3,500 | 3,430 | 3,442 | -73 | -2.1% | 156,600 |
| 2025/06/18 | 3,512 | 3,541 | 3,509 | 3,515 | -8 | -0.2% | 113,900 |
| 2025/06/17 | 3,546 | 3,572 | 3,523 | 3,523 | -44 | -1.2% | 116,100 |
| 2025/06/16 | 3,644 | 3,644 | 3,567 | 3,567 | -79 | -2.2% | 167,000 |
| 2025/06/13 | 3,660 | 3,660 | 3,613 | 3,646 | -28 | -0.8% | 108,900 |
| 2025/06/12 | 3,705 | 3,722 | 3,650 | 3,674 | -23 | -0.6% | 159,300 |
| 2025/06/11 | 3,670 | 3,751 | 3,661 | 3,697 | +152 | +4.3% | 263,600 |
| 2025/06/10 | 3,552 | 3,575 | 3,529 | 3,545 | -31 | -0.9% | 126,000 |
| 2025/06/09 | 3,567 | 3,582 | 3,534 | 3,576 | +42 | +1.2% | 123,900 |
| 2025/06/06 | 3,535 | 3,561 | 3,510 | 3,534 | +30 | +0.9% | 171,600 |
| 2025/06/05 | 3,534 | 3,534 | 3,494 | 3,504 | -30 | -0.8% | 89,900 |
| 2025/06/04 | 3,510 | 3,544 | 3,510 | 3,534 | +15 | +0.4% | 121,700 |
| 2025/06/03 | 3,554 | 3,554 | 3,478 | 3,519 | -31 | -0.9% | 192,800 |
| 2025/06/02 | 3,547 | 3,553 | 3,512 | 3,550 | -11 | -0.3% | 169,600 |
| 2025/05/30 | 3,490 | 3,574 | 3,486 | 3,561 | +66 | +1.9% | 229,200 |
| 2025/05/29 | 3,497 | 3,505 | 3,429 | 3,495 | +45 | +1.3% | 262,100 |
| 2025/05/28 | 3,455 | 3,469 | 3,430 | 3,450 | +13 | +0.4% | 123,300 |
| 2025/05/27 | 3,428 | 3,451 | 3,421 | 3,437 | +22 | +0.6% | 99,900 |
| 2025/05/26 | 3,455 | 3,465 | 3,411 | 3,415 | -38 | -1.1% | 123,400 |
| 2025/05/23 | 3,450 | 3,475 | 3,442 | 3,453 | +3 | +0.1% | 111,800 |
| 2025/05/22 | 3,384 | 3,461 | 3,382 | 3,450 | +35 | +1% | 189,100 |
| 2025/05/21 | 3,420 | 3,443 | 3,390 | 3,415 | +14 | +0.4% | 109,100 |
| 2025/05/20 | 3,439 | 3,452 | 3,387 | 3,401 | -6 | -0.2% | 217,100 |
| 2025/05/19 | 3,410 | 3,434 | 3,386 | 3,407 | +11 | +0.3% | 197,300 |
| 2025/05/16 | 3,325 | 3,399 | 3,313 | 3,396 | +84 | +2.5% | 219,200 |
| 2025/05/15 | 3,316 | 3,322 | 3,285 | 3,312 | -39 | -1.2% | 176,200 |
| 2025/05/14 | 3,386 | 3,425 | 3,333 | 3,351 | -90 | -2.6% | 232,000 |
| 2025/05/13 | 3,379 | 3,470 | 3,376 | 3,441 | +157 | +4.8% | 487,600 |
| 2025/05/12 | 3,367 | 3,384 | 3,267 | 3,284 | -79 | -2.3% | 455,400 |
| 2025/05/09 | 3,416 | 3,448 | 3,357 | 3,363 | -51 | -1.5% | 414,800 |
| 2025/05/08 | 3,554 | 3,564 | 3,402 | 3,414 | -70 | -2% | 528,600 |
| 2025/05/07 | 3,713 | 3,761 | 3,470 | 3,484 | -251 | -6.7% | 763,400 |
| 2025/05/02 | 3,706 | 3,760 | 3,688 | 3,735 | +33 | +0.9% | 225,000 |
| 2025/05/01 | 3,676 | 3,727 | 3,661 | 3,702 | +25 | +0.7% | 147,700 |
| 2025/04/30 | 3,675 | 3,700 | 3,639 | 3,677 | +38 | +1% | 111,500 |
| 2025/04/28 | 3,620 | 3,664 | 3,620 | 3,639 | +20 | +0.6% | 128,800 |
| 2025/04/25 | 3,617 | 3,651 | 3,596 | 3,619 | +12 | +0.3% | 88,100 |
| 2025/04/24 | 3,623 | 3,652 | 3,607 | 3,607 | -6 | -0.2% | 109,200 |
| 2025/04/23 | 3,626 | 3,648 | 3,604 | 3,613 | +13 | +0.4% | 150,800 |
| 2025/04/22 | 3,565 | 3,605 | 3,543 | 3,600 | +30 | +0.8% | 108,700 |
| 2025/04/21 | 3,595 | 3,599 | 3,542 | 3,570 | -52 | -1.4% | 141,400 |
| 2025/04/18 | 3,587 | 3,622 | 3,547 | 3,622 | +55 | +1.5% | 97,700 |
| 2025/04/17 | 3,547 | 3,570 | 3,542 | 3,567 | -4 | -0.1% | 109,900 |
| 2025/04/16 | 3,560 | 3,613 | 3,546 | 3,571 | +41 | +1.2% | 180,400 |
| 2025/04/15 | 3,540 | 3,584 | 3,516 | 3,530 | +18 | +0.5% | 106,500 |
| 2025/04/14 | 3,487 | 3,569 | 3,466 | 3,512 | +86 | +2.5% | 193,900 |
251～
300
件表示中 / 3978件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 413,000円 | +17.1% | +5.9% | 3.00% | 9.18倍 | 0.95倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 152,450円 | +19.1% | -10.3% | 0.00% | 8.88倍 | 2.34倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ロート | 253,200円 | +7.5% | -3.9% | 1.97% | 16.58倍 | 1.89倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| ツムラ | 378,300円 | +10.9% | -11.3% | 4.18% | 10.76倍 | 0.88倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 東和薬品 | 410,500円 | +11.1% | +6.8% | 2.07% | 9.40倍 | 1.14倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
